| ≥1 piece |
| Vitamin D3 Basic information |
| Product Name: | Vitamin D3 |
| Synonyms: | RACUMIN D;OLEOVITAMIN D3;(+)-VITAMIN D3;VITAMIN D3;VITAMIN D;(3beta,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol;(5E,7E)-9,10-Secocholesta-5,7,10-trien-3-ol;10-Secocholesta-5,7,10(19)-trien-3-ol,(3.beta.,5Z,7E)-9 |
| CAS: | 67-97-0 |
| MF: | C27H44O |
| MW: | 384.64 |
| EINECS: | 200-673-2 |
| Product Categories: | Miscellaneous Natural Products;Vitamin D3 analogs;Vitamins - Deuterated;Nutritional Supplements;Vitamins and derivatives;Chiral Reagents;Intermediates & Fine Chemicals;Pharmaceuticals;Vitamin Ingredients;Miscellaneous Compounds;Vitamin series;DROMOS;Other APIs |
| Mol File: | 67-97-0.mol |
| Vitamin D3 Chemical Properties |
| mp | 83-86 °C(lit.) |
| alpha | 105 º (c=0.8, EtOH 25 ºC) |
| storage temp. | 2-8°C |
| Water Solubility | <0.1 g/L (20 ºC) |
| Sensitive | Air & Light Sensitive |
| Merck | 14,10019 |
| BRN | 2339331 |
| CAS DataBase Reference | 67-97-0(CAS DataBase Reference) |
| NIST Chemistry Reference | Cholecalciferol(67-97-0) |
| EPA Substance Registry System | 9,10-Secocholesta- 5,7,10(19)-trien-3-ol, (3.beta.,5Z,7E)-(67-97-0) |
| Safety Information |
| Hazard Codes | T+,T |
| Risk Statements | 24/25-26-48/25-23/24/25 |
| Safety Statements | 28-36/37-45-28A-36/37/39 |
| RIDADR | UN 2811 6.1/PG 2 |
| WGK Germany | 2 |
| RTECS | VS2900000 |
| F | 8-10-23 |
| HazardClass | 6.1 |
| PackingGroup | II |
| HS Code | 29130000 |
| HS Code | 29362990 |
| Hazardous Substances Data | 67-97-0(Hazardous Substances Data) |
| MSDS Information |
| Provider | Language |
|---|---|
| 9,10-Secocholesta-5,7,10(19)-trien-3beta-ol | English |
| SigmaAldrich | English |
| ACROS | English |
| ALFA | English |
| Vitamin D3 Usage And Synthesis |
| Chemical Properties | Crystalline |
| Usage | vitamin D3 |
| Usage | carnitine replenisher in peripheral arterial disease |
| Usage | The vitamin that mediates intestinal calcium absorbtion, bone calcium metabolism and probably, muscle activity. Occurs in and is isolated from fish liver oils. Vitamin D acts through a receptor that i s a member of the ligand-dependent transcription factor superfamily. Modulates the proliferation and differentiation of both normal and cancer cells. Has antiproliferative and antimetastatic effects o n breast, colon, and prostate cancer cells. Activated vitamin D receptors in intestine and bone maintain calcium absorbance and homeostasis. |
| Usage | selective phosphodiesterase-4 inhibitor (PDE-4 inhibitor) under investigation for treating respiratory diseases involving chronic inflammation such as asthma or COPD (smoker’s lung) |
| General Description | Fine colorless crystals. Water insoluble. |
| Air & Water Reactions | Sensitive to moisture, air and light. . Water insoluble. |
| Reactivity Profile | Vitamin D3 may react vigorously with strong oxidizing agents. May react exothermically with reducing agents to release hydrogen gas. |
| Health Hazard | SYMPTOMS: Symptoms of exposure to Vitamin D3 may include weakness, fatigue, lassitude headache, nausea, vomiting, diarrhea, polyuria, polydipsia, nocturia, decrease urinary concentrating ability, proteinuria, tissue calcification, hypertension and osteoporosis. |
| Fire Hazard | Flash point data for Vitamin D3 are not available. Vitamin D3 is probably combustible. |
| Vitamin D3 Preparation Products And Raw materials |
| Preparation Products | COD LIVER OIL |
| Raw materials | Cyclohexane-->PASSION FLOWER OIL-->Silica glass-->7-Dehydrocholesterol |